Publikationen im NUM

Hier finden Sie eine Liste der Publikationen, die im Zusammenhang mit dem Netzwerk Universitätsmedizin in der ersten und zweiten Förderphase entstanden sind.

Mühlemann B, et al . Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalised COVID-19 patients - results from a prospective observational study. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2021;      [DOI] 
Mühlemann B, Thibeault C, Hillus D, Helbig E, Lippert L, Tober-Lau P, Schwarz T, Müller M, group P, Witzenrath M, others . Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study. Clin Microbiol Infect. 2021;      [DOI] 
Ricke-Hoch M, Stelling E, Lasswitz L, Gunesch A, Kasten M, Zapatero-Belinchón F, Brogden G, Gerold G, Pietschmann T, Montiel V, Balligand J, Facciotti F, Hirsch E, Gausepohl T, Elbahesh H, Rimmelzwaan G, Höfer A, Kühnel M, Jonigk D, Eigendorf J, Tegtbur U, Mink L, Scherr M, Illig T, Schambach A, Pfeffer T, Hilfiker A, Haverich A, Hilfiker-Kleiner D. Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. PLoS One. 2021 Aug.; 16(8):e0255335.      [DOI] 
Dauletbaev N, Kuhn S, Holtz S, Waldmann S, Niekrenz L, Müller BS, Bellinghausen C, Dreher M, Rohde GGU, Vogelmeier C. Implementation and use of mHealth home telemonitoring in adults with acute COVID-19 infection: A scoping review protocol. BMJ Open. 2021; 11(9):e053819.      [DOI] 
Müller A, Melzow FS, Göstemeyer G, Paris S, Schwendicke F. Implementation of COVID-19 Infection Control Measures by German Dentists: A Qualitative Study to Identify Enablers and Barriers. International Journal of Environmental Research and Public Health. 2021; 18(11):5710.      [DOI] 
Hennig V, et al . Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia. Orphanet Journal of Rare Diseases. 2021; 16373.      [DOI] 
Weiner J, Suwalski P, Holtgrewe M, Rakitko A, Thibeault C, Müller M, Patriki D, Quedenau C, Krüger U, Ilinsky V, others . Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01. EClinicalMedicine. 2021;      [DOI] 
Dickel S, Grimm C, Popp M, Struwe C, Sachkova A, Golinski M, Seeber C, Fichtner F, Heise D, Kranke P, Meissner W, Laudi S, Voigt-Radloff S, Meerpohl J, Jabs J, Mutters N, Moerer O, Group On Behalf Of The German CEOsys Study . Infection control, prophylactic antibiotics, and testing for SARS-CoV-2 and PPE on German intensive care units: results from a national mixed methods survey. GMS Hyg Infect Control. 2021; 16Doc21.      [DOI] 
Köster AM, Bludau A, Devcic SK, Scheithauer S, Mardiko AA, Schaumann R. Infection surveillance measures during the COVID-19 pandemic in Germany. GMS hygiene and infection control. 2021; 16Doc27.      [DOI] 
Köster A, Bludau A, Devcic S, et al . Infection surveillance measures during the COVID-19 pandemic in Germany. GMS Hyg Infect Control. 2021; 16      [DOI] 
Wyler E, Adler JM, Eschke K, Alves GT, Peidli S, Pott ea. Insights into standards of care – dexamethasone and antibodies against COVID-19 in hamster models. bioRxiv. 2021;      [DOI] 
Houwaart T, Belhaj S, Tawalbeh E, et al . Integrated Genomic Surveillance reveals extensive onward transmission of travel-imported SARS-CoV-2 infections in the community. MedRxiv. 2021;      [DOI] 
Schroeder S, Pott F, Niemeyer D, Veith T, Richter A, Muth ea. Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics. Lancet Microbe. 2021; 2e210—e218.      [DOI] 
Burns J, Movsisyan A, Stratil J, Biallis R, Coenen M, Emmert-Fees K, Geffert K, Hoffmann S, Horstick O, Laxy M, Klinger C, Kratzer S, Litwin T, Norris S, Pfadenhauer L, Philipsborn P, Sell K, Stadelmaier B, Voss S, Wabnitz K, Rehfuess E. International travel-related control measures to contain the COVID-19 pandemic: a rapid review. Cochrane Database of Systematic Reviews. 2021; 3      [DOI] 
Strobl S, Roth W. Internationale wissenschaftliche Publikationsaktivität zu COVID-19 [International publication activity during the COVID-19 pandemic]. Pathologe. 2021; 42(2):224-230.
Andreas M, Piechotta V, Skoetz N, Grummich K, Becker M, Joos L, Becker G, Meissner W, Boehlke C. Interventions for palliative symptom control in COVID-19 patients. Cochrane Database of Systematic Reviews. 2021; 2021(8):CD015061.      [DOI] 
Andreas M, Piechotta V, Skoetz N, Grummich K, Becker M, Joos S, Becker G, Meissner W, Boehlke C. Interventions for palliative symptom control in COVID-19 patients. Cochrane Database of Systematic Reviews. 2021; CD015061.      [DOI] 
Halwe S, Kupke A, Vanshylla K, et al . Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection. Viruses. 2021; 13(8):      [DOI]      [Datei] 
Halwe S, et al . Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. Viruses. 2021; 13      [DOI] 
Bošnjak B, et al . Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents. Frontiers in Immunology. 2021; 12772240.      [DOI] 
Bošnjak B, Odak I, Barros-Martins J, et al . Intranasal delivery of MVA vector vaccine induces effective pulmonary immunity against SARS-CoV-2 in rodents. Front Immunol. 2021; 12      [DOI]      [Datei] 
Popp M, Stegemann M, Metzendorf M, Gould S, Kranke P, Meybohm P, Skoetz N, Weibel S. Ivermectin for preventing and treating COVID‐19. Cochrane Database of Systematic Reviews. 2021; 2021CD015017.      [DOI] 
Malin JJ, Spinner CD, Janssens U, Welte T, Weber-Carstens S, Schälte G, Gastmeier P, Langer F, Wepler M, Westhoff M, Pfeifer M, Rabe KF, Hoffmann F, Böttiger BW, Weinmann-Menke J, Kersten A, Berlit P, Krawczyk M, Nehls W, Fichtner F, Laudi S, Stegemann M, Skoetz N, Nothacker M, Marx G, Karagiannidis C, Kluge S. Key summary of German national treatment guidance for hospitalized COVID-19 patients Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021). Infection. 2021;      [DOI] 
Vanshylla K, et al . Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans. Cell host & microbe. 2021;      [DOI] 
Schmidt M, Löwe C, Kugai S, Thielmann A, Weltermann B. Kommunikations- und Kooperationsstrukturen von Hausärzt*innen und Gesundheitsämtern – Erkenntnisse der egePan-Studie. DocV-22-02. 2021;      [DOI] 
Stillfried S, Acker T, Aepfelbacher M, Baretton G, Bülow RD, Bürrig KF, Holtherm UH, Jonigk D, Knüchel R, Majeed RW, Röhrig R, Wienströer J, Boor P. Kooperatives Vorgehen der Pathologie und Neuropathologie in der COVID-19-Pandemie : Deutsches Register für COVID-19-Obduktionen (DeRegCOVID) und Deutsches Netzwerk für Autopsien in Pandemien (DEFEAT PANDEMIcs) [Cooperative approach of pathology and neuropathology in the COVID-19 pandemic : German registry for COVID-19 autopsies (DeRegCOVID) and German network for autopsies in pandemics (DEFEAT PANDEMIcs)]. Pathologe. 2021; 42(2):216-223.
Ludwig KU, Schmithausen RM, Li D, et al . LAMP-Seq enables sensitive, multiplexed COVID-19 diagnostics using molecular barcoding. Nat Biotechnol. 2021; 39(12):      [DOI]      [Datei] 
Englisch CN, Tschernig T, Flockerzi F, Meier C, Bohle RM. Lesions in the lungs of fatal coronavirus disease COVID-19. Ann Anat. 2021; 234151657.      [DOI] 
Theobald SJ, et al . Long-lived macrophage reprogramming drives spike protein–mediated inflammasome activation in COVID–19. EMBO Mol Med. 2021;      [DOI] 
Knolle P, Körber N, Priller A, et al . Long-term follow-up of SARS-CoV-2 convalescents reveals distinct magnitude of spike-specific immunity after viral re-exposure and vaccination. Research Square. 2021;      [DOI] 
Horn A, Krist L, Lieb W, Montellano F, Kohls M, Haas K, Gelbrich G, Bolay-Gehrig S, Morbach C, Reese J, others . Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Infection. 2021; 49(6):1277—1287.      [DOI] 
Tober-Lau P, et al . Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers. The Lancet Respiratory Medicine. 2021; 9e104-e105.      [DOI] 
Jan\'ıková M, Hodosy J, Boor P, Klempa B, Celec P. Loop-mediated isothermal amplification for the detection of SARS-CoV-2 in saliva. Microb Biotechnol. 2021; 14(1):307-316.      [DOI] 
Contreras S, Dehning J, Mohr SB, Bauer S, Spitzner FP, Priesemann V. Low case numbers enable long-term stable pandemic control without lockdowns. Science advances. 2021; 7(41):eabg2243.      [DOI] 
Kuhlmann E, Heinemann S, Bludau A, et al . Managing protection and surveillance of health workers during COVID-19: German multi-centre survey. Eur J Public Health. 2021; 31(Supplement 3):      [DOI] 
Holfelder M, et al . Medical Device Regulation Efforts for mHealth Apps during the COVID-19 Pandemic—An Experience Report of Corona Check and Corona Health. J. 2021; 4206—222.      [DOI] 
Bartels C, Hessmann P, Schmidt U, Vogelgsang J, Ruhleder M, Kratzenberg A, Treptow M, Reh-Bergen T, Abdel-Hamid M, Heß L, Meiser M, Signerski-Krieger J, Radenbach K, Trost S, Schott BH, Wiltfang J, Wolff-Menzler C, Belz M. Medium-term and peri-lockdown course of psychosocial burden during the ongoing COVID-19 pandemic: A longitudinal study on patients with pre-existing mental disorders. European Archives of Psychiatry and Clinical Neuroscience. 2021;      [DOI] 
Stiel S, Schneider N. Mehr Nähe am Lebensende trotz Pandemie ermöglichen – MHH untersucht im Forschungsverbund PallPan Auswirkungen auf ambulante Palliativversorgung. MHH Insight. 2021;      [DOI] 
Jung N, Simon ST. Menschenwürdige Begleitung auch unter Pandemiebedingungen ein Muss! – Nationale Strategie mit 33 Handlungsempfehlungen. Zeitschrift für Palliativmedizin. 2021; 22(05):229-230.      [DOI] 
Kunzler AM, Röthke N, Günthner L, Stoffers-Winterling J, Tüscher O, Coenen M, Rehfuess E, Schwarzer G, Binder H, Schmucker C, Meerpohl JJ, Lieb K. Mental burden and its risk and protective factors during the early phase of the SARS-CoV-2 pandemic: systematic review and meta-analyses. Global Health. 2021; 17(1):34.      [DOI] 
Kunzler AM, Stoffers-Winterling J, Stoll M, Mancini AL, Lehmann S, Blessin M, Gilan D, Helmreich I, Hufert F, Lieb K. Mental health and psychosocial support strategies in highly contagious emerging disease outbreaks of substantial public concern: A systematic scoping review. PloS one. 2021; 16(2):e0244748.      [DOI] 
Iannizzi C, Dorando E, Burns J, Weibel S, Dooley C, Wakeford H, Estcourt LJ, Skoetz N, Piechotta V. Methodological challenges for living systematic reviews conducted during the COVID-19 pandemic: a concept paper. Journal of Clinical Epidemiology. 2021;      [DOI] 
Iannizzi C, Akl EA, Kahale LAea. Methods and guidance on conducting, reporting, publishing and appraising living systematic reviews: a scoping review protocol [version 1; peer review: 1 approved]. F1000Research. 2021; 10802.      [DOI]      [Datei] 
Ackermann M, Jonigk D. Microvascular placental alterations in maternal COVID-19. Am J Obstet Gynecol. 2021;      [DOI] 
Stemler J, Kramer T, Dimitriou V, et al . Mobile PCR-based surveillance for SARS-CoV-2 to reduce visiting restrictions in nursing homes during the COVID-19 pandemic: a pilot study. Infection. 2021;      [DOI] 
Schneider JN, Hiebel N, Kriegsmann-Rabe M, Schmuck J, Erim Y, Morawa E, Jerg-Bretzke L, Beschoner P, Albus C, Hannemann J, Weidner K, Steudte-Schmiedgen S, Radbruch L, Brunsch H, Geiser F. Moral Distress in Hospitals During the First Wave of the COVID-19 Pandemic: A Web-Based Survey Among 3,293 Healthcare Workers Within the German Network University Medicine. Frontiers in Psychology. 2021; 125295.      [DOI]      [Datei] 
Muzoora MR, et al . Motivating Developers to Use Interoperable Standards for Data in Pandemic Health Apps. Stud Health Technol Inform. 2021; 2811027—1028.      [DOI] 
Ondruschka B, Heinrich F, Lindenmeyer M, Edler C, Möbius D, Czogalla J, Heinemann A, Braun F, Aepfelbacher M, Lütgehetmann M, Huber TB. Multiorgan tropism of SARS-CoV-2 lineage B.1.1.7. Int J Legal Med. 2021;      [DOI] 
Walsh C, Tafforeau P, Wagner W, et al . Multiscale three-dimensional imaging of intact human organs down to the cellular scale using hierarchical phase-contrast tomography. Nat Methods. 2021;      [DOI] 
Wong DW, Klinkhammer BM, Djudjaj S, Villwock S, Timm MC, Buhl EM, Wucherpfennig S, Cacchi C, Braunschweig T, Knüchel-Clarke R, Jonigk D, Werlein C, Bülow RD, Dahl E, Stillfried S, Boor P. Multisystemic Cellular Tropism of SARS-CoV-2 in Autopsies of COVID-19 Patients. Cells. 2021; 10(8):1900.      [DOI]